Document is current
Any future updates will be listed below
-
Authors
Kushki, Azadeh https://orcid.org/0000-0003-1510-8818
Anagnostou, Evdokia
Hammill, Christopher
Duez, Pierre
Brian, Jessica
Iaboni, Alana
Schachar, Russell
Crosbie, Jennifer
Arnold, Paul
Lerch, Jason P.
-
Funding
Funding for this research was provided by:
Ontario Brain Institute (IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02, IDS-I l-02)
- License Information
-
More Information
Article History
Received: 12 March 2019
Revised: 4 October 2019
Accepted: 20 October 2019
First Online: 26 November 2019
Conflict of interest
: Dr. Kushki holds a patent for the device “Anxiety Meter”. Dr. Anagnostou has served as a consultant to Roche. She has received grant funding from SanofiCanada and SynapDx. She holds a patent for the device, “Anxiety Meter”. She has received royalties from APPI and Springer. Dr. Schachar has consulted to Highland Therapeutics, Eli Lilly and Co., and Purdue Pharma. He has commercial interest in a cognitive rehabilitation software company, “eHave”. Dr. Arnold holds a patent for ‘SLCIAI Marker for Anxiety Disorder’ granted May 6, 2008. The remaining authors declare no conflict of interest.
